--- title: What You Are Really Paying For When a Hearing Aid Costs $5,000 description: AI is now in every premium hearing aid. Here is whether a $5,000 prescription aid is worth it over $249 AirPods or a $500 OTC aid, and what actually matters. author: Dr Marina Nani (Editor-in-Chief) updated: 2026-08-24T13:16:52.887Z canonical: https://richhealthmagazine.com/article/what-you-are-really-paying-for-when-a-hearing-aid-costs-5-000 categories: Longevity & Science content_type: Guide region: Global publication: Rich Health Magazine schema_type: Article --- On August 24, Signia, one of the brands owned by hearing-aid giant WS Audiology, released a new flagship prescription aid called MaX, built around four deep neural networks it markets as "Acoustic Intelligence." But the launch is most useful as a marker of where the whole market now sits: artificial intelligence is no longer a premium add-on in hearing aids, it is standard across every high-end device. Every major maker now sells a device that uses on-board neural networks to pull speech out of noise, which changes the question a buyer actually faces. If the smart processing is everywhere, what are you paying $5,000 for, and could a $249 pair of AirPods do the job instead? ## AI Is Already Standard Across the Premium Tier Signia's MaX runs four task-specific neural networks at once, each trained on a different job: the speech you are trying to follow, your own voice, the room around you, and the background noise. Signia says the chip driving them has 54 times more processing power, 50 percent greater energy efficiency and twice the memory of its previous platform, and that in the company's own testing 97 percent of wearers do better in noisy group conversations than with key competitors. The first device, the Pure C&G MaX, is a receiver-in-canal aid with a pocket charger, eight color options and support for Bluetooth, LE Audio, Telecoil and Auracast streaming. Impressive on paper, and Signia is a serious maker. But on-board neural processing is not new, and it is not unique to Signia. Starkey put out an aid it billed as the first with AI back in 2018. Oticon shipped the first hearing aid with an on-board deep neural network in 2020. Today Phonak, Starkey and ReSound all sell devices that use neural networks to separate speech from noise, and the field is crowded. The count of neural networks a company advertises is a marketing figure, not a performance rating. When Hearing Tracker's independent lab measured real speech-in-noise results, Phonak's top device outscored Starkey's, and MaX, released this week, has not yet been through any independent benchmark. Signia's Jose Alves, who heads the brand, frames the goal as helping wearers follow "dynamic group conversations that happen in noisy, multi-talker environments." That is the right target, and it is the target every premium maker is now aiming at. ## Cheaper Devices Now Cover Milder Hearing Loss For years the honest answer to "is there a budget option" was no. That has changed. In September 2024 the FDA authorized Apple's AirPods Pro 2, at $249, to work as [over-the-counter hearing aids](https://www.aarp.org/health/conditions-treatments/info-2024/apple-airpods-hearing-aids.html). A peer-reviewed study found they matched dedicated over-the-counter amplifiers on word recognition and on sentences in noise for people with mild-to-moderate loss, though independent testers still rate them only middling for the hardest listening situations. Standalone over-the-counter aids, which you buy without a prescription or a fitting, run from about $199 to $2,700 and average near $500. Set that against a premium prescription pair, which costs roughly $3,500 to $7,500 and averages around $4,600. The gap in price is enormous, and for milder loss the gap in benefit has narrowed. So the case for spending more rests on two things the cheaper route cannot supply. The first is fitting: an audiologist tunes a prescription aid to your specific hearing test, verifies it with real-ear measurement, and adjusts it over time, which matters more as loss gets deeper or more lopsided between ears. The second is follow-through: over-the-counter aids come back at a high rate, with roughly a third to half returned, often because the sound disappoints and there is no professional to dial it in. ## Hearing Loss Is the Largest Modifiable Dementia Risk in Mid-Life The strongest reason to treat hearing loss is the one that rarely comes up in a showroom. It is also [easy to put off](https://richhealthmagazine.com/article/hearing-well-why-high-achievers-ignore-their-hearing-issues). The 2024 Lancet Commission on dementia named hearing loss the single largest modifiable risk factor from mid-life onward, and the NIH-funded ACHIEVE trial found that [treating hearing loss with aids](https://www.achievestudy.org/fast-facts-hearing-loss-dementia) slowed cognitive decline by about 48 percent over three years in older adults at higher risk. What the aids buy you here does not come from the brochure specs. It comes from wearing them day in and day out, which is exactly why fit, comfort and follow-up carry more weight than a neural-network count. Which route suits you follows from that. For mild-to-moderate loss and a tight budget, an over-the-counter set or the AirPods you may already own is a real entry point, and one you will actually wear beats an expensive pair left in a drawer. For more severe, more complex or uneven loss, or for anyone who has tried the cheaper path and given up, a prescription aid and the professional behind it earn their price. What does not earn it is buying the highest neural-network number on the box. Signia MaX is available through hearing care professionals; details are at [signia.net](https://www.signia.net/en-us/). ## FAQ **Q: Can AirPods Pro 2 really work as hearing aids?** Yes, within limits. The FDA authorized them as over-the-counter hearing aids in September 2024 for adults with mild-to-moderate loss, and a peer-reviewed study found they held their own against dedicated amplifiers on word recognition and sentences in noise. They are weaker in the most demanding noisy settings, and they are not designed for severe loss. **Q: What is the difference between OTC and prescription hearing aids?** Over-the-counter aids are sold directly to you, without a hearing test or professional fitting, for mild-to-moderate loss. Prescription aids are selected and tuned by an audiologist to your specific hearing, verified with real-ear measurement, and adjusted over time, which matters most for deeper or more complex loss. **Q: How much do AI hearing aids cost?** A premium prescription pair runs roughly $3,500 to $7,500, averaging around $4,600. Over-the-counter aids range from about $199 to $2,700 and average near $500. AirPods Pro 2, authorized for hearing use, are $249. **Q: Does treating hearing loss lower dementia risk?** Hearing loss is the largest modifiable dementia risk factor from mid-life on, per the 2024 Lancet Commission, and the ACHIEVE trial found aids slowed cognitive decline by about 48 percent over three years in higher-risk older adults. The benefit depends on wearing the aids consistently. **Q: Do more DNNs make a hearing aid better?** Not on their own. The number of neural networks a maker advertises is a marketing figure. Independent lab testing of measured speech-in-noise performance does not line up with the highest DNN count, so look for independent results and a good fitting rather than the biggest number on the box.